Results 181 to 190 of about 207,525 (262)
Obinutuzumab in systemic lupus erythematosus: a real-world experience. [PDF]
Wu C +10 more
europepmc +1 more source
Dysregulation of U12‐Type Splicing in Lupus Neutrophils
Abstract. Objective Neutrophil dysfunction is a hallmark of systemic lupus erythematosus (SLE), but its molecular basis remains unclear. This study explores transcriptional and post‐transcriptional changes in low‐density granulocytes (LDGs), a proinflammatory neutrophil subset expanded in SLE, focusing on NADPH oxidase (Nox) function and minor intron ...
Luz P. Blanco +11 more
wiley +1 more source
Correction: Obinutuzumab in systemic lupus erythematosus: a real-world experience. [PDF]
Wu C +10 more
europepmc +1 more source
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun +4 more
wiley +1 more source
Telitacicept for systemic lupus erythematosus-associated peripheral neuropathy: a case report. [PDF]
Tan J +8 more
europepmc +1 more source
Biomaterial design strategies for enhancing mitochondrial transplantation therapy
Biomaterials to facilitate mitochondrial transplantation therapy: biomaterials as barriers to protect mitochondria from pathophysiological microenvironments, like osmotic stress caused by the excessive concentration of calcium ion, reactive oxygen species, and advanced glycation end products; biomaterials integrating with biochemical cues to improve ...
Shaoyang Kang +12 more
wiley +1 more source
Calcinosis Cutis in a Patient With Systemic Lupus Erythematosus: A Case Report. [PDF]
Osman Ahmed Osman M +5 more
europepmc +1 more source
Anemia in systemic lupus erythematosus.
King Hei Stanley Lam, Thuan-Chong Quah
openalex +1 more source

